Cargando…

Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia

Myocardial ischemia (MI) is one of the most common cardiovascular diseases with high incidence and mortality. Huang-Lian-Jie-Du-Tang (HLJDT) is a classic traditional Chinese prescription to clear “heat” and “poison”. In this study, we used a deliberate strategy integrating the methods of network pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Dai, Weixing, Li, Wenting, Zhang, Yumao, Wu, Yanqin, Guan, Chenfeng, Zhang, Anye, Huang, Hui, Li, Yuzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890363/
https://www.ncbi.nlm.nih.gov/pubmed/33613277
http://dx.doi.org/10.3389/fphar.2020.589175
_version_ 1783652501162033152
author Li, Li
Dai, Weixing
Li, Wenting
Zhang, Yumao
Wu, Yanqin
Guan, Chenfeng
Zhang, Anye
Huang, Hui
Li, Yuzhen
author_facet Li, Li
Dai, Weixing
Li, Wenting
Zhang, Yumao
Wu, Yanqin
Guan, Chenfeng
Zhang, Anye
Huang, Hui
Li, Yuzhen
author_sort Li, Li
collection PubMed
description Myocardial ischemia (MI) is one of the most common cardiovascular diseases with high incidence and mortality. Huang-Lian-Jie-Du-Tang (HLJDT) is a classic traditional Chinese prescription to clear “heat” and “poison”. In this study, we used a deliberate strategy integrating the methods of network pharmacology, pharmacodynamics, and metabonomics to investigate the molecular mechanism and potential targets of HLJDT in the treatment of MI. Firstly, by a network pharmacology approach, a global view of the potential compound-target-pathway network based on network pharmacology was constructed to provide a preliminary understanding of bioactive compounds and related targets of HLJDT for elucidating its molecular mechanisms in MI. Subsequently, in vivo efficacy of HLJDT was validated in a rat model. Meanwhile, the corresponding metabonomic profiles were used to explore differentially induced metabolic markers thus providing the metabolic mechanism of HLJDT in treating MI. The results demonstrated the myocardial protection effect of HLJDT on ischemia by a multicomponent-multitarget mode. This study highlights the reliability and effectiveness of a network pharmacology-based approach that identifies and validates the complex of natural compounds in HLJDT for illustrating the mechanism for the treatment of MI.
format Online
Article
Text
id pubmed-7890363
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78903632021-02-19 Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia Li, Li Dai, Weixing Li, Wenting Zhang, Yumao Wu, Yanqin Guan, Chenfeng Zhang, Anye Huang, Hui Li, Yuzhen Front Pharmacol Pharmacology Myocardial ischemia (MI) is one of the most common cardiovascular diseases with high incidence and mortality. Huang-Lian-Jie-Du-Tang (HLJDT) is a classic traditional Chinese prescription to clear “heat” and “poison”. In this study, we used a deliberate strategy integrating the methods of network pharmacology, pharmacodynamics, and metabonomics to investigate the molecular mechanism and potential targets of HLJDT in the treatment of MI. Firstly, by a network pharmacology approach, a global view of the potential compound-target-pathway network based on network pharmacology was constructed to provide a preliminary understanding of bioactive compounds and related targets of HLJDT for elucidating its molecular mechanisms in MI. Subsequently, in vivo efficacy of HLJDT was validated in a rat model. Meanwhile, the corresponding metabonomic profiles were used to explore differentially induced metabolic markers thus providing the metabolic mechanism of HLJDT in treating MI. The results demonstrated the myocardial protection effect of HLJDT on ischemia by a multicomponent-multitarget mode. This study highlights the reliability and effectiveness of a network pharmacology-based approach that identifies and validates the complex of natural compounds in HLJDT for illustrating the mechanism for the treatment of MI. Frontiers Media S.A. 2021-02-04 /pmc/articles/PMC7890363/ /pubmed/33613277 http://dx.doi.org/10.3389/fphar.2020.589175 Text en Copyright © 2021 Li, Dai, Li, Zhang, Wu, Guan, Zhang, Huang and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Li
Dai, Weixing
Li, Wenting
Zhang, Yumao
Wu, Yanqin
Guan, Chenfeng
Zhang, Anye
Huang, Hui
Li, Yuzhen
Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia
title Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia
title_full Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia
title_fullStr Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia
title_full_unstemmed Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia
title_short Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia
title_sort integrated network pharmacology and metabonomics to reveal the myocardial protection effect of huang-lian-jie-du-tang on myocardial ischemia
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890363/
https://www.ncbi.nlm.nih.gov/pubmed/33613277
http://dx.doi.org/10.3389/fphar.2020.589175
work_keys_str_mv AT lili integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT daiweixing integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT liwenting integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT zhangyumao integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT wuyanqin integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT guanchenfeng integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT zhanganye integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT huanghui integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia
AT liyuzhen integratednetworkpharmacologyandmetabonomicstorevealthemyocardialprotectioneffectofhuanglianjiedutangonmyocardialischemia